1-Tosylaziridine
| Purity | Grade | Package | Stock | Price | Quantity |
|---|---|---|---|---|---|
| 98% | RG | 5G | In Stock | 35 USD | |
| 98% | RG | 25G | In Stock | 145 USD | |
| 98% | RG | 100G | In Stock | 550 USD | |
NMR spectrum of 3634-89-7
Safety Information of 3634-89-7
Download COA of 3634-89-7
Applications of 3634-89-7
N-Tosylaziridine serves multiple applications in organic synthesis:
- Synthetic Intermediates: They are used as intermediates in the synthesis of complex organic molecules, including pharmaceuticals and agrochemicals.
- Building Blocks: The compound acts as a building block for constructing various nitrogen-containing heterocycles, enhancing its utility in synthetic chemistry.
Biological Activity of 3634-89-7
Research indicates that N-tosylaziridine derivatives exhibit biological activity, particularly in the field of medicinal chemistry. These compounds can serve as precursors for various bioactive molecules, including potential pharmaceuticals. Their ability to form diverse scaffolds through chemical transformations makes them attractive for drug discovery.
Bulk Packaging Price Explanation of 3634-89-7
Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.
Purchase Instructions of 3634-89-7
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.
These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.
Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.

